Lazarus J M, Wick G, Borella L
Fresenius Medical Care North America, Lexington, MA 02420-9192, USA.
Adv Ren Replace Ther. 1999 Jan;6(1):59-66. doi: 10.1016/s1073-4449(99)70009-9.
This is a brief review of the history of utilization of quality indicators by a major dialysis provider and how those indicators have been modified in response to the National Kidney Foundation-Dialysis Outcomes Quality Initiative (NKF-DOQI). Fresenius Medical Care North America (FMCNA) has monitored adequacy of dialysis, anemia management, and nutrition therapy for a number of years, using a self-directed continuous quality improvement program. FMCNA supports the NKF-DOQI Guidelines and has used the DOQI as it continues to enhance its patient quality care program. Specific goals and action thresholds of that program are delineated.
